More News
18 March 2013
Proteologics and GlaxoSmithKline (GSK) Extend Their Research Collaboration for an Additional Year18 March 2013
AstraZeneca to establish strategic R&D centres to enhance innovation and pipeline productivity14 March 2013
Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled Melphalan13 March 2013
Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease12 March 2013
Shire Acquires Premacure AB12 March 2013
Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors9 March 2013
Galapagos and Roche conclude strategic alliance6 March 2013
Targacept and AstraZeneca Amend Collaboration6 March 2013
Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology5 March 2013
Addex Partners with Viva Biotech to Advance Allosteric Modulators Targeting Adenosine 2A Receptor28 February 2013
UCB to license worldwide rights to tozadenant in Parkinson’s disease from Biotie Therapies28 February 2013
Takeda and Resolve Therapeutics Enter Autoimmune Partnership27 February 2013
Araxes Pharma Enters Into Cancer Drug Discovery and Development Agreement With Janssen Biotech27 February 2013
Aciex Enters Into Collaborative Research Agreement with Portola to Develop Dual Syk/JAK Inhibitors for Ophthalmic Indications27 February 2013
Antisense Pharma unveils its corporate strategy for 201326 February 2013
Xellia Enters 4 Year Collaboration to Develop New Antibiotics to Combat Multi-Drug Resistant Bacteria25 February 2013
Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal25 February 2013
Cubist Announces Exclusive Option to Acquire Adynxx25 February 2013
ABLYNX AND SPIROGEN ENTER INTO A RESEARCH COLLABORATION TO EVALUATE THE POTENTIAL OF NOVEL TOXIN-NANOBODY DRUG CONJUGATES IN CANCER24 February 2013
BioMarin Licenses Factor VIII Gene Therapy Program for Hemophilia A From University College London and St. Jude Children’s Research HospitalNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports